Crossmark

A comparative analysis of clinical outcomes between conversion to mTOR inhibitor and calcineurin inhibitor reduction in managing BK viremia among kidney transplant patients

Crossref DOI link: https://doi.org/10.1038/s41598-024-60695-2

Published Online: 2024-06-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Cho, Ara

Park, Sunghae

Han, Ahram

Ha, Jongwon

Park, Jae Berm

Lee, Kyo Won

Min, Sangil
License Information

Text and Data Mining valid from 2024-06-04

Version of Record valid from 2024-06-04
More Information

Article History

Received: 20 November 2023

Accepted: 26 April 2024

First Online: 4 June 2024

Competing interests

: This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI23C1591).

Document is current

Any future updates will be listed below